Skip to main content


February 2021 and lockdown continues, the rate of progress in vaccinating the UK is on track and offers us hope for the future. For many who haven't actually suffered illness I think these may have been the toughest weeks yet. Dark days and nights followed by a week of freezing and below. The views from our campus are pretty but the chilling winds have taken their toll on the amount of time spent outside. Lab work continues with progress being made in all our projects. We have two new pre-prints which are also undergoing review at PlosOne and Aging. Fingers crossed that these are received well.

Comments

Popular posts from this blog

Dr. Brad Ebanks - Graduation day!

  Well here we are...in some car park area outside the graduation hall. Just like Brad's PhD... starting in the year 2019/20... it's not ideal, but we made it work! Delighted to have been able to see Brad graduate and to meet his family yesterday! These occasions are the absolute highlight of my academic life - Thank you!

We were able to contribute to two articles appearing this month in Science and Nature Aging!

Epigenetic networks and ageing in 348 mammalian species...including our bats!
New research by a Nottingham academic linking the neurodegenerative disease Parkinson’s to changes in a protein in brain mitochondria is to receive support from a prestigious US funding agency. Dr Lisa Chakrabarti, at The University of Nottingham, will receive $75,000 for a one-year research project from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), which is dedicated to finding a cure for Parkinson’s and funds promising research that could result in new treatments to slow, stop or reverse the progression of the disease. Dr Chakrabarti said: “We are trying to look at mitochondrial biology from a totally different perspective, which could have important implications for Parkinson’s and other neurodegenerative diseases. The funding from The Michael J. Fox Foundation will help us to confirm whether some of the protein changes we see in Parkinson’s are related to disease course.” http://exchange.nottingham.ac.uk/research/parkinsons-study-receives-fu